RP-A601

N/A

Report date: 2026/04/08 15:42:22

Base Information

Drug NameRP-A601
Drug Alias NameRP-A601
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPlakophilin-2 gene transference
TargetsPlakophilin-2
Therapy Area/IndicationsArrhythmias, CardiacArrhythmogenic Right Ventricular Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRocket Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRocket Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsArrhythmias, CardiacArrhythmogenic Right Ventricular Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A